To provide an expanded access protocol designed to provide rMBCG to patients with non-muscle invasive bladder cancer (NMIBC) who are eligible to receive TICE BCG, may benefit from its use, &am...
Current Studies
Clinical trials advance medical treatment and therapy to increase survival and quality of life.
Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.
Successful treatments we know today are the result of past clinical trials.
Filter your results
By specialty
- Cardiology (1)
- COVID-19 (1)
- Gastroenterology (1)
- Genetics (1)
- Hematology (1)
- Neurovascular (1)
- Oncology/Cancer (20)
- Orthopedics (1)
- Pain Management (2)
- Pediatric Gastroenterology (1)
- Pulmonary (4)
- Radiation Therapy (10)
- Rheumatology (1)
- Urology (5)
By disease or condition
- Bladder Cancer (1)
- Breast Cancer (1)
- Cancer (10)
- Cancer Screening (2)
- Chronic Pain (2)
- COVID-19 (1)
- Erectile Dysfunction (1)
- Erosive Esophagitis (1)
- Hepatocellular Carcinoma (2)
- Ischemic Stroke (1)
- Leukemia (1)
- Lupus (SLE) (1)
- Male Overactive Bladder (1)
- Metastatic Colorectal Cancer (2)
- Multiple Myeloma (1)
- Non-Small Cell Lung Cancer (1)
- Oropharyngeal Cancer (2)
- Osteoarthritis (1)
- Prostate Cancer (4)
- Prostatectomy (1)
- Radiation Therapy (3)
- Ulcerative Colitis (1)
- Urinary Urge Incontinence (UUI) (2)
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab inCombination with Platinum-based Chemotherapy for the First-line Treatment of Patients with MetastaticSquamous Non-small Cell Lung Cancer...
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st Line t...
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab inCombination with Platinum-based Chemotherapy for the First-line Treatment of Patients with MetastaticNon-squamous Non-small Cell Lung Cancer Whose...
The purpose of ARTEMIDE-Lung03 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st L...
Adjuvant WIDER
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on...
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform Lesions
The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorectal cancer (mCRC) patients who develop...
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in rea...
Dosimetric comparison study with different treatment technique, planning, & imaging system
To assess the dosimetric impact on radiation therapy with different treatment protocol, technique & planning system.
...CIVCO / CQ Medical Pro-Lok Motion Management Project
The purpose of this work is to quantify the effect of the forced shallow breathing patient motion management technique on lung tumors using the CIVCO Respiratory Belt (“Pro-Lok”) and 4-D Computed T...
A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients from Minority Populations Underrepresented in Prior Fruquintinib Studies
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American...
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer (COMPPARE)
This study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes [quality of life (QOL), toxicity, and disease control] between parallel cohorts of men with prostate...
